FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine

Date: January 11, 2021 Issue #:  1615Summary:  The FDA has issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech mRNA-based vaccine for prevention of COVID-19 in persons≥16 years old.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: COVID-19 vaccines Source Type: research